Edwards Lifesciences Corp
Extracted from this filing and checked against the source text.
Edwards Lifesciences Corp shareholders approved The approval of the Company’s Amended and Restated Long-Term Stock Incentive Compensation Program at the 2024-05-07 meeting.
Proposal 4 : The approval of the Company’s Amended and Restated Long-Term Stock Incentive Compensation Program was approved as set forth below:View on SEC.gov
Edwards Lifesciences Corp shareholders approved Election of Directors at the 2024-05-07 meeting.
All the nominees for director listed in Proposal 1 were elected to serve until the Company’s next annual meeting of stockholders and until their respective successors are duly elected and qualified as set forth below:View on SEC.gov
Edwards Lifesciences Corp shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-07 meeting.
Proposal 3 : Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 was approved as set forth below:View on SEC.gov
Edwards Lifesciences Corp shareholders approved Advisory proposal regarding the Company’s named executive officer compensation at the 2024-05-07 meeting.
Proposal 2 : The advisory proposal regarding the Company’s named executive officer compensation was approved as set forth below:View on SEC.gov
210 shareholder votes filed in the last 30 days. Browse all shareholder votes →
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.